Peter B. Corr, PhD, is a Non-Executive Director on the Board of Directors of ADC Therapeutics, as well as Co‑Founder and Managing General Partner of Auven Therapeutics Management.
He retired from Pfizer Inc. in December 2006, where he was Senior Vice President for Science and Technology. Previously, Dr. Corr served as Executive Vice President, Pfizer Global Research & Development, and Senior Vice President, Discovery Research, at Monsanto/Searle and then as President of Pharmaceutical Research and Development at Warner Lambert/Parke Davis. He spent 18 years at Washington University in St. Louis as Professor, Department of Medicine (Cardiology) and Department of Pharmacology and Molecular Biology.
He has held a number of Chairmanships, including the Science & Regulatory Executive Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA), the PhRMA Foundation Board of Directors, and the Hever Group.
Dr. Corr is a past Governor and Chair of the New York Academy of Sciences, a member of the Board of Regents of Georgetown University, and a Chairman of the Board of the International Partnership for Microbicides and of the Critical Path Institute. Dr. Corr also served on the boards of Furiex Pharmaceuticals, Inc., Global Edit, Inc., and the African Leadership Congress.